期刊文献+

全反式维甲酸对脑肿瘤干细胞增殖和分化的影响

Effect of aH-trans retinoic acid on proliferation and differentiation of brain tumor stem cells in vitro
原文传递
导出
摘要 目的研究全反式维甲酸(ATRA)对脑肿瘤干细胞(BTSCs)增殖和分化的影响。方法采用有限稀释法从人脑胶质母细胞瘤新鲜标本中分离、克隆筛选BTSCs;在无血清条件下培养BTSCs,根据培养基中的成分不同分为对照组、ATRA组、ATRA/生长因子组、生长因子组,用MTT法检测BTSCs的增殖效应;在含血清条件下诱导分化BTSCs,根据血清培养基中的成分不同分为ATRA组、对照组,于诱导分化第10天用免疫荧光技术检测BTSCs子代分化细胞CD133和胶质纤维酸性蛋白(GFAP)的表达率;将BTSCs子代分化细胞更换培养条件,观察其在无血清培养基中增殖逆转再次形成脑肿瘤干细胞球(BTS)的比例和形成时间。结果在无血清条件下,ATRA组BTSCs的增殖速度较对照组明显加快,但低于生长因子组和ATRA/生长因子组,形成的BTS亦小于后两者;在含血清条件下,ATRA组BTSCs子代分化细胞CD133、GFAP的表达率分别为2.29%±0.27%和75.60%±4.03%,对照组为7.05%±0.49%和12.51%±0.77%,前者的分化程度明显高于后者,差异有统计学意义(P〈0.05),但前者仍然存在CD133的表达;BTSCs子代分化细胞在回复无血清条件下能够再次增殖形成BTS,ATRA组再形成BTS的比例为4.84%±0.32%,形成时间为(10.07±1.03)d,对照组分别为17.71%±0.78%和(4.08±0.35)d,前者再形成BTS的比例较后者更低、时间更长,差异有统计学意义(P〈0.05)。结论ATRA能促进BTSCs增殖并诱导BTSCs子代细胞走向分化,但分化不彻底,细胞不能达到终末分化,可再次形成BTS。 Objective To investigate the effect of all-trans retinoic acid (ATRA) on the proliferation and differentiation of brain tumor stem cells (BTSCs) in vitro. Methods Freshly resected glioblastoma multiforme tissues were obtained from 3 surgical patients, and BTSCs were isolated by limited dilution and clonogenic assay. The BTSCs obtained were cultured in serum-free medium and divided into control group, ATRA group, growth factor group, and ATRA/growth factor group with corresponding treatments. The proliferation of the treated BTSCs was evaluated using MTT assay. The BTSCs were induced in serum-containing medium and treated with ATRA or diluted solvent, and the expression of CD133 and glial fibrillary acidic protein (GFAP) in the cells were detected by immunofluorescence on day 10 of induction. The differentiated BTSCs were cultured in serum-free medium, and the percentage of and time needed for cell sphere formation were observed. Results The proliferation of BTSCs in ATRA group was faster than that in the control group and slower than that in growth factor group and ATRA/growth factor group, and the size of brain tumor sphere (BTS) in ATRA group was smaller than that in the latter two groups. The percentage of CD133 and GFAP-positive differentiated BTSCs were (2.29±0.27)% and (75.60±4.03)% in ATRA group, and (7.05±0.49)% and (12.51±0.77)% in the control group, respectively. The differentiation rate of BTSCs was significantly higher in ATRA group than in the control group (P〈0.05), and some of the differentiated BTSCs expressed CD133. The differentiated BTSCs could form BTS in serum-free medium, and in ATRA group, the percentage of BTS formation was significantly lower and time need for BTS formation was significantly longer than those in the control group [(4.84±0.32)% vs (17.71±0.78)%, P〈0.05; 10.07±1.03 vs 4.08±0.35 days, P〈0.05]. Conclusion ATRA can promote the proliferation and induce the differentiation of BTSCs, but the differentiated BTSCs can not achieve terminal differentiation and tend to form BTS again.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2009年第3期240-245,共6页 Chinese Journal of Neuromedicine
基金 国家自然科学基金(30672166)
关键词 全反式维甲酸 脑肿瘤干细胞 细胞增殖 细胞分化 All-trans retinoic acid Brain ~maor stem cells Proliferation Differentiation
  • 相关文献

参考文献10

  • 1Haque A, Banik NL, Ray SK all-trans retinoic acid Emerging role of combination of and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma [J]. Neurochem Res, 2007, 32(12): 2203-2209.
  • 2车晓明,崔大明,汪洋,施炜,刘天津,王柯.胶质母细胞瘤肿瘤干细胞体外分离培养鉴定及生物学特性的研究[J].中国临床神经科学,2007,15(6):561-569. 被引量:9
  • 3Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors [J]. Cancer Res, 2003, 63 (18): 5821-5828.
  • 4Galli R, Binda E, Orfanelli U, et al. Isolation and characterization of tumorigenic,stem-like neural precursors from human glioblastoma [J]. Cancer Res, 2004, 64(19): 7011-7021.
  • 5Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain turnout initiating cells[J]. Nature, 2004, 432(7015): 396-401.
  • 6Kondo T, Setoguchi T, Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line [J]. Proc Natl Acad Sci USA, 2004, 101(3): 781-786.
  • 7Zang C, Wachter M, Liu H, et al. Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas[J]. J Neurooncol, 2003, 65(2): 107-118.
  • 8Kaba SE, Kyritsis AP, Conrad C, et al. The treatment of recurrent cerebral gliomas with all-trans-retinoic acid (tretinoin) [J]. J Neurooncol, 1997, 34(2): 145-151.
  • 9Phuphanich S, Scott C, Fischbach AJ, et al. All-trans-retinoic acid: a phase Ⅱ Radiation Therapy Oncology Group study(RTOG 91-13) in patients with recurrent malignant astrocytoma[J]. J Neurooncol, 1997, 34(2): 193-200.
  • 10牛锋,邓艳春.肿瘤干细胞与脑胶质瘤干细胞的研究现状[J].中华神经医学杂志,2007,6(11):1174-1177. 被引量:3

二级参考文献34

  • 1姜晓兵,周凤,姚东晓,刘如恩,张方成,赵洪洋.人脑胶质瘤肿瘤干细胞的培养及鉴定[J].脑与神经疾病杂志,2005,13(1):6-8. 被引量:12
  • 2李茗初,邓永文,伍军,陈风华,刘劲芳,方加胜.髓母细胞瘤中脑肿瘤干细胞的分离培养及鉴定[J].癌症,2006,25(2):241-246. 被引量:22
  • 3陈刚,秦尚振,马廉亭,雷霆,潘力,薛德麟.人胚神经干细胞的体外培养和超微结构观察[J].中国临床神经外科杂志,2006,11(2):92-94. 被引量:10
  • 4崔大明,车晓明.脑肿瘤干细胞的研究进展[J].中国临床神经科学,2006,14(6):662-665. 被引量:2
  • 5Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells[J]. Nature, 2001, 414(6859): 105-111.
  • 6SELL S. Stem cell origin of cancer and differentiation therapy [J]. Crit Rev Oncol Hematol, 2004, 51 (1): 1-28.
  • 7Hanahan D, Weinberg RA. The hallmarks of cancer [J]. Cell, 2000, 100(1): 57-70.
  • 8Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell [J]. Nat Med, 1997, 3(7): 730-737.
  • 9Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors[J]. Cancer Res, 2003, 63(18): 5821-5828.
  • 10Hemmati HD, Nakano I, Lazareff JA, et al. Cancerous stem cells can arise from pediatric brain tumors[J]. Proc Natl Acad Sci USA, 2003, 100(25): 15178-15183.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部